Relating to prior authorization for prescription drug benefits related to the treatment of chronic health conditions.

HB 2557 limits prior authorization requirements for prescription drugs treating chronic health conditions. It prohibits insurance plans from demanding more than one annual prior authorization for such drugs, covering conditions like autoimmune diseases, hemophilia, and neurodegenerative disorders. The bill defines "chronic health condition" as illnesses expected to last over a year that require ongoing care or limit daily activities (e.g., bathing, walking). This change applies only to plans delivered, issued, or renewed on or after January 1, 2026, with the law taking effect September 1, 2025.